“Latest Stem Cells News”

Image via Wikipedia

As former House speaker Newt Gingrich courts evangelical voters in advance of Tuesday’s Florida primary, he is drawing an increasingly hard line against the use of embryonic stem-cell research — a position that contrasts not only with that of former Massachusetts governor Mitt Romney, but also with statements that Gingrich himself has made on the subject in the past.

Speaking at a Baptist church in Winter Park on Saturday, the former speaker received a standing ovation when he declared that embryonic stem-cell research amounts to “the use of science to desensitize society over the killing of babies.”

And in a news conference Sunday, he said he would ban all embryonic stem-cell research, including that done on discarded embryos created by in vitro fertilization.

Incoming search terms:

Howie Lindeman was facing the loss of his career and Neim Malo wasn’t supposed to see 2011. They were each treated for heart disease years ago using their own stem cells to repair their damaged heart tissue. Several years following treatment, both men continue to see improvement in their condition and quality of life.

Howie Lindeman, 60, had a heart attack at 39 years old that severely damaged his heart. He went through several procedures including having stents placed in his arteries and his physicians were considering open heart surgery for a quintuple bypass. He was in constant pain and struggled to walk just 25 feet, but when Zannos G. Grekos, MD, MAAC, FACC, chief medical officer of Regenocyte and a Florida-based pioneer in the field of adult stem cell therapy suggested he have the Regenocyte Adult Stem Cell procedure, he jumped at the opportunity. A normal ejection fraction (EF) is over 50 percent and Lindeman’s was down to a dangerous 22 percent before the adult stem cell procedure. Shortly after receiving treatment, his EF improved to a near-normal 47 percent, and is now at a stable 54 percent.

Incoming search terms:

Stem Cell Research and Therapy for Cardiomyopathy

Adult Stem Cell research has performed another miracle and it is fitting that it is a Reverend who has been helped this time for his dilated cardiomyopathy and congestive heart failure. Reverend Dan Jackson, of Colorado has reported that his ejection fraction has more than doubled after a stem cell treatment using his own Adult Stem Cells.

When Dan’s dilated cardiomyopathy caused his ejection fraction to drop to 21% and into congestive heart failure, he knew he was in trouble. His son Duke took to the internet to find help.

Vescell Adult Stem Cells for Heart Disease

That was when he found Vescell Adult Stem Cells, by Theravitae. Theravitae uses the patient’s own stem cells to treat heart disease and peripheral artery disease. However, money was an issue. Duke helped take care of that by having multiple fundraisers to help fund the stem cell treatment.

Dan and his wife traveled to Thailand in November for his stem cell therapy in which he had his own Adult Stem Cells injected into his heart muscle.

Incoming search terms:

An international team of physicians and scientists in Florida have discovered a way to treat cardiomyopathy (heart disease) with adult stem cells, including a rare metabolic condition otherwise requiring heart transplant.

Regenocyte Therapeutic is using stem cells extracted from patients’ blood to repair damaged heart muscle, regenerate tissue, and create new vessels to improve circulation. According to the organization’s director of Cardiology and Vascular Disease, Zannos G. Grekos, M.D., by applying specific growth factors to the patient’s stem cells  the team creates a new cell population which is educated to target the area of damage or deficiency when placed into the patient’s heart and blood vessels. “We’ve now treated close to 100 patients with their own stem cells and seen an average 22 point increase in ejection fraction (EF) with a significant improvement in heart failure classification – typically from a Class IV to a Class II status in less than 180 days,” Grekos says.

The cardiomyopathy treatment study, the first 6 months of which was published December 2008 in Anti-Aging Medical News, follows patients through one year post-treatment with autologous adult stem cells, also called Angiogenic Cardio-Regenerative Progenitor cells (ACP’s). Regenocyte’s chief medical advisor Athina Kyritsis, M.D. announced that, “Across the board, no adverse effects from treatment were reported by patients and function plus quality of life measurably improved.” Grekos and his team measured patients’ heart function by cardiac nuclear scans, PET scans, and echocardiographs.

Incoming search terms: